Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

about

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

Item

http://www.wikidata.org/entity/Q37124737

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on September 2016

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

@en

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer.

@nl

type

Item

label

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

@en

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer.

@nl

prefLabel

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

@en

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer.

@nl

P1476

Dyspnea as a Prognostic Factor in Patients with Non-Small Cell Lung Cancer

@en

P2093

Chang Dong Yeo

http://www.w3.org/2001/XMLSchema#string

Hwa Sik Moon

http://www.w3.org/2001/XMLSchema#string

Hyeon Hui Kang

http://www.w3.org/2001/XMLSchema#string

Jick Hwan Ha

http://www.w3.org/2001/XMLSchema#string

Jong Min Lee

http://www.w3.org/2001/XMLSchema#string

Sang Haak Lee

http://www.w3.org/2001/XMLSchema#string

Woo Ho Ban

http://www.w3.org/2001/XMLSchema#string

P2860

Global cancer statistics

Reduced lung-cancer mortality with low-dose computed tomographic screening

Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary

The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease.

COPD prevalence is increased in lung cancer, independent of age, sex and smoking history.

Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.

Therapy-induced toxicity of the lungs: an overview.

Clinical impact of prevalence and severity of COPD on the decision-making process for therapeutic management of lung cancer patients

Exposing a deadly alliance: novel insights into the biological links between COPD and lung cancer.

Lung cancer survival and stage at diagnosis in Australia, Canada, Denmark, Norway, Sweden and the UK: a population-based study, 2004-2007.

P304

1063-1069

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3349/YMJ.2016.57.5.1063

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Chin Kook Rhee

P577

2016-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27401635

http://www.w3.org/2001/XMLSchema#string

P932

4960370

http://www.w3.org/2001/XMLSchema#string